๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for High-risk PCI

Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions NCT07093788NA3 sites๐Ÿ“ Lianyungang๐Ÿ“ Nanjing๐Ÿ“ Yixing Nanjing First Hospital, Nanjing Medical University ยท Tests: super high-pressure balloon, intravascular lithotripsy (IVL) Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures NCT07380217NA8 sites๐Ÿ“ Amsterdam๐Ÿ“ Geleen๐Ÿ“ Groningen Amsterdam UMC, location VUmc ยท Tests: Mechanical circulatory support with the Pulsecath iVAC2L device Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention NCT04899479Phase 41 site๐Ÿ“ Seoul Samsung Medical Center ยท Tests: SGLT2 inhibitor, Control Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction NCT07537296n/a2 sites๐Ÿ“ Nanjing๐Ÿ“ Nanjing Nanjing First Hospital, Nanjing Medical University ยท Tests: Cardiac CT Follow-up and Echocardiographic Follow-up IVUS CHIP China Registry NCT06274645n/a1 site๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: The OptiCross High Definition (60 MHz) and OptiCross (40MHz) Intravascular Ultrasound (IVUS) catheter from Boston Scienโ€ฆ Prognosis and Antiplatelet Strategies for Patients With PCI and High Bleeding Risk:A Study Protocol NCT05369442n/a1 site๐Ÿ“ Sichuan West China Hospital Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI NCT07149714NA1 site๐Ÿ“ Moscow National Medical Research Center for Cardiology, Ministry oโ€ฆ ยท Tests: iVAC 2L Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients NCT05923489NA1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Routine Angiography Follow-up, Routine Clinical Follow-up LEADERS FREE IV (RCT): BioFreedomโ„ข Ultra vs BioFreedomโ„ข in HBR Patients NCT06657326NA6 sites๐Ÿ“ Johor Bahru๐Ÿ“ Kuantan๐Ÿ“ Ipoh Biosensors Europe SA ยท Tests: BioFreedomโ„ข Ultra cobalt-chromium Biolimus A9โ„ข-coated stent, BioFreedomโ„ข stainless steel Biolimus A9โ„ข-coated stent Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention NCT06274411NA1 site๐Ÿ“ Beijing Beijing Anzhen Hospital ยท Tests: Standby cannulated ECMO, Prophylactic ECMO Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty. NCT07582835Phase 31 site๐Ÿ“ Lugano Cardiocentro Ticino ยท Tests: Clopidogrel, Ticagrelor, Prasugrel Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy NCT04416581Phase 445 sites๐Ÿ“ Anyang๐Ÿ“ Bucheon-si๐Ÿ“ Busan Duk-Woo Park, MD ยท Tests: PPI, P-CAB 50 Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI NCT04814212NA14 sites๐Ÿ“ Jyvรคskylรค๐Ÿ“ Rovaniemi๐Ÿ“ Kuopio North Karelia Central Hospital ยท Tests: Percutaneous coronary intervention using drug-coated balloon, Percutaneous coronary intervention using drug-eluting steโ€ฆ Efficacy and Safety of a Beet-Derived Inorganic Nitrate-Based Food Product for the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention NCT06984406NA1 site๐Ÿ“ Moscow National Medical Research Center for Therapy and Preventiveโ€ฆ ยท Tests: Beet-Derived Inorganic Nitrate-Based Food Product PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm NCT06445608NA18 sites๐Ÿ“ Chandler๐Ÿ“ Scottsdale๐Ÿ“ Little Rock Kardion Inc ยท Tests: Percutaneous Mechanical Circulatory Support Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE) NCT07009418NA22 sites๐Ÿ“ Bucheon-si๐Ÿ“ Daegu๐Ÿ“ Daegu Samsung Medical Center ยท Tests: Coronary CT Angiography (CCTA) A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients. NCT03998319Phase 322 sites๐Ÿ“ Bankstown๐Ÿ“ Camperdown๐Ÿ“ Concord University of Sydney ยท Tests: Tenecteplase (1/3 systemic weight based dose), Sterile water for injection (WFI) Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2) NCT07025148Phase 41 site๐Ÿ“ Jacksonville University of Florida ยท Tests: Prasugrel, Clopidogrel Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention NCT04240834Phase 41 site๐Ÿ“ Beijing Fu Wai Hospital, Beijing, China ยท Tests: Aspirin, Ticagrelor Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) NCT07296744NA25 sites๐Ÿ“ Loma Linda๐Ÿ“ Sacramento๐Ÿ“ Thousand Oaks Supira Medical ยท Tests: The Supira System, Impella ELEVATE High-Risk PCI Pivotal Study NCT07001332NA33 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ La Jolla Magenta Medical Ltd. ยท Tests: Elevate, Impella Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction NCT05262803Phase 46 sites๐Ÿ“ Aalborg๐Ÿ“ Copenhagen๐Ÿ“ Hellerup Rikke Sorensen ยท Tests: CYP2C19*2/*3, Shorter DAPT duration Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial NCT05782777NA1 site๐Ÿ“ Seoul Yonsei University ยท Tests: ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg), high-intensity statin monโ€ฆ Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome. NCT06486233n/a1 site๐Ÿ“ Ho Chi Minh City Gia Dinh People Hospital Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation NCT06863155n/a13 sites๐Ÿ“ Albacete๐Ÿ“ Alicante๐Ÿ“ Badajoz Fundaciรณn EPIC ยท Tests: Supraflex Cruz Sirolimus-eluting Stent Interventional Left Ventricular Assist System for PCI in CHIP Patients NCT07053618NA15 sites๐Ÿ“ Beijing๐Ÿ“ Xiamen๐Ÿ“ Lanzhou Suzhou Hengruihongyuan Medical Technology Co. LTD ยท Tests: Implantation of the VADLINK Percutaneous Left Ventricular Assist Device, VA-ECMO Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation NCT06558474n/a1 site๐Ÿ“ Eindhoven Cathreine BV ยท Tests: Liberal post-dilatation strategy during PCI Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome NCT07366684n/a1 site๐Ÿ“ Niลก Clinical Center Niลก ยท Tests: Percutaneous Coronary Intervention (PCI), Conservative Medical Therapy Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention NCT06186037Phase 41 site๐Ÿ“ Suwon Saint Vincent's Hospital, Korea ยท Tests: Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg, Mono drug group of Rosuvastatin 20 mg Feasibility Study of the Supira System in Patients Undergoing HRPCI With Support Beyond the PCI Procedure NCT07407816NA2 sites๐Ÿ“ Tbilisi๐Ÿ“ Tbilisi Supira Medical ยท Tests: Supira System
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy